Table of Contents
Ketek™ (Telithromycin) NDA 21-144 Efficacy Review
Outline
Indications
Acute Exacerbation of Chronic Bronchitis
Acute Exacerbation of Chronic Bronchitis
Acute Exacerbation of Chronic Bronchitis
Acute Exacerbation of Chronic Bronchitis
Acute Sinusitis
Acute Sinusitis
Acute Sinusitis
Community-Acquired Pneumonia
Community-Acquired Pneumonia
Community-Acquired Pneumonia
Community-Acquired Pneumonia
Community-Acquired Pneumonia
Drug-Resistant S. pneumoniae
CAP: Drug-Resistant S. pneumoniae Telithromycin MIC
CAP: Drug-Resistant S. pneumoniae
CAP: Drug-Resistant S. pneumoniae
CAP: Drug-Resistant S. pneumoniae
CAP: Drug-Resistant S. pneumoniae
CAP: Drug-Resistant S. pneumoniae Bacteremia Patients
CAP: Drug-Resistant S. pneumoniae Cases from Japanese Studies
AS: Drug-Resistant S. pneumoniae
AS: Drug-Resistant S. pneumoniae
Acknowledgments
|